Stay updated on M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a backend version update and does not affect the displayed study details.
    Difference
    0.1%
    Check dated 2026-03-12T00:58:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the operating-status notice and Revision: v3.4.1. These appear to be site maintenance updates rather than changes to the study details.
    Difference
    0.5%
    Check dated 2026-02-11T13:57:32.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH operations status has been added, along with a version update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:50:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI-related changes include adding a glossary display option, minor wording changes such as capitalization in labels (e.g., Last Update Submitted that Met QC Criteria vs Last Update Submitted that met QC Criteria and No FEAR Act Data), and a new revision label v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:45:05.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4, indicating a minor maintenance update. No substantive changes to study content, eligibility criteria, or contact information are apparent.
    Difference
    0.1%
    Check dated 2026-01-14T02:21:12.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a new Locations section with the Texas site details and updated the record to Revision 3.3.3; removed the previous Texas Locations entry and the HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-12-23T17:25:47.000Z thumbnail image

Stay in the know with updates to M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial page.